Matthew D. Eitner serves as Executive at Hoth Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Matthew D. Eitner has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2019 involved exercising options for 15,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 20, 2019 | HOTH | $0 | Conversion | 15,000 | $N/A | Discretionary |
Matthew D. Eitner currently holds 765,000 shares of Hoth Therapeutics, Inc. (HOTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew D. Eitner has been a net neutral trader of HOTH stock. They have purchased $0 and sold $0 worth of shares.
Matthew D. Eitner's most recent insider trade was on Feb 20, 2019, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted